|
1
|
Klein R, Klein BE, Moss SE, Davis MD and
DeMets DL: The Wisconsin epidemiologic study of diabetic
retinopathy. II. Prevalence and risk of diabetic retinopathy when
age at diagnosis is less than 30 years. Arch Ophthalmol.
102:520–526. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brownlee M: The pathobiology of diabetic
complications: A unifying mechanism. Diabetes. 54:1615–1625. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ding J and Wong TY: Current epidemiology
of diabetic retinopathy and diabetic macular edema. Curr Diab Rep.
12:346–354. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu H, Wu H, Shi L, Yuan X, Yin Y, Yuan M,
Zhou Y, Hu Q, Jiang K and Dong J: The association of haptoglobin
gene variants and retinopathy in type 2 diabetic patients: A
meta-analysis. J Diabetes Res. 2017:21950592017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu H, Geng X, Zhang X, Qiu M, Jiang K,
Tang L and Dong J: A self-adaptive distance regularized level set
evolution method for optical disk segmentation. Biomed Mater Eng.
24:3199–3206. 2014.PubMed/NCBI
|
|
6
|
Wu HQ, Wu H, Shi LL, Yu LY, Wang LY, Chen
YL, Geng JS, Shi J, Jiang K and Dong JC: The association between
retinal vasculature changes and stroke: A literature review and
Meta-analysis. Int J Ophthalmol. 10:109–114. 2017.PubMed/NCBI
|
|
7
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chiu HS, Somvanshi S, Patel E, Chen TW,
Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS, Sood AK, et al:
Cancer Genome Atlas Research Network: Pan-cancer analysis of lncRNA
regulation supports their targeting of cancer genes in each tumor
context. Cell Rep. 23:297–312.e12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Sun X, Icli B and Feinberg MW:
Emerging roles for MicroRNAs in diabetic microvascular disease:
Novel targets for therapy. Endocr Rev. 38:145–168. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan B, Tao ZF, Li XM, Zhang H, Yao J and
Jiang Q: Aberrant expression of long noncoding RNAs in early
diabetic retinopathy. Invest Ophthalmol Vis Sci. 55:941–951. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kovacs B, Lumayag S, Cowan C and Xu S:
MicroRNAs in early diabetic retinopathy in streptozotocin-induced
diabetic rats. Invest Ophthalmol Vis Sci. 52:4402–4409. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang LQ, Cui H, Wang L, Fang X and Su S:
Role of microRNA-29a in the development of diabetic retinopathy by
targeting AGT gene in a rat model. Exp Mol Pathol. 102:296–302.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Q, Qiu F, Zhou K, Matlock HG,
Takahashi Y, Rajala RV, Yang Y, Moran E and Ma JX: Pathogenic role
of microRNA-21 in diabetic retinopathy through downregulation of
PPARα. Diabetes. 66:1671–1682. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye Z, Li ZH and He SZ: miRNA-1273g-3p
involvement in development of diabetic retinopathy by modulating
the autophagy-lysosome pathway. Med Sci Monit. 23:5744–5751. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gomaa AR, Elsayed ET and Moftah RF:
MicroRNA-200b expression in the vitreous humor of patients with
proliferative diabetic retinopathy. Ophthalmic Res. 58:168–175.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang C, Wu D, Gao L, Liu X, Jin Y, Wang D,
Wang T and Li X: Competing endogenous RNA networks in human cancer:
Hypothesis, validation, and perspectives. Oncotarget.
7:13479–13490. 2016.PubMed/NCBI
|
|
18
|
Wang Y, Hou J, He D, Sun M, Zhang P, Yu Y
and Chen Y: The emerging function and mechanism of ceRNAs in
cancer. Trends Genet. 32:211–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song C, Zhang J, Liu Y, Pan H, Qi HP, Cao
YG, Zhao JM, Li S, Guo J, Sun HL and Li CQ: Construction and
analysis of cardiac hypertrophy-associated lncRNA-mRNA network
based on competitive endogenous RNA reveal functional lncRNAs in
cardiac hypertrophy. Oncotarget. 7:10827–10840. 2016.PubMed/NCBI
|
|
21
|
Jiang H, Ma R, Zou S, Wang Y, Li Z and Li
W: Reconstruction and analysis of the lncRNA-miRNA-mRNA network
based on competitive endogenous RNA reveal functional lncRNAs in
rheumatoid arthritis. Mol BioSyst. 13:1182–1192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang C, Yuan N, Wu L, Wang X, Dai J, Song
P, Li F, Xu C and Zhao X: An integrated analysis for long noncoding
RNAs and microRNAs with the mediated competing endogenous RNA
network in papillary renal cell carcinoma. OncoTargets Therapy.
10:4037–4050. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin
YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al: miRTarBase
2016: Updates to the experimentally validated miRNA-target
interactions database. Nucleic Acids Res. 44:D239–D247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao F, Zuo Z, Cai G, Kang S, Gao X and Li
T: miRecords: An integrated resource for microRNA-target
interactions. Nucleic Acids Res. 37:D105–D110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bozec A, Zangari J, Butori-Pepino M, Ilie
M, Lalvee S, Juhel T, Butori C, Brest P, Hofman P and
Vouret-Craviari V: MiR-223-3p inhibits angiogenesis and promotes
resistance to cetuximab in head and neck squamous cell carcinoma.
Oncotarget. 8:57174–57186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang L, Li R, He J, Yang Q, Wu Y, Huang J
and Wu B: Co-expression analysis among microRNAs, long non-coding
RNAs, and messenger RNAs to understand the pathogenesis and
progression of diabetic kidney disease at the genetic level.
Methods. 124:46–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baldeón Rojas L, Weigelt K, de Wit H,
Ozcan B, van Oudenaren A, Sempértegui F, Sijbrands E, Grosse L, van
Zonneveld AJ, Drexhage HA and Leenen PJ: Study on
inflammation-related genes and microRNAs, with special emphasis on
the vascular repair factor HGF and miR-574-3p, in monocytes and
serum of patients with T2D. Diabetol Metab Syndr. 8:62016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li F, Chen H, Huang Y, Zhang Q, Xue J, Liu
Z and Zheng F: miR-34c plays a role of tumor suppressor in HEC1-B
cells by targeting E2F3 protein. Oncol Rep. 33:3069–3074. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu X, Wang QL, Li YF, Wang XD, Xu A and Li
Y: A novel miR-200b-3p/p38IP pair regulates monocyte/macrophage
differentiation. Cell Discov. 2:150432016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu J, Cui H, Zhu Z and Wang L:
MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and
inhibits tumor growth of glioma through down-regulation of ERK5.
Biochem Biophys Res Commun. 478:1158–1164. 2016. View Article : Google Scholar : PubMed/NCBI
|
